THOMAS, T.V. et al. 2025. EXPANSION STRATEGIES TO DESIGN HYBRID MOLECULES OF FDA APPROVED DRUGS AS POTENTIAL INHIBITORS OF SARS Co-V-2 MAIN PROTEASE (Mpro). International Journal of Applied Pharmaceutics. 17, 2 (Mar. 2025), 153–164. DOI:https://doi.org/10.22159/ijap.2025v17i2.53121.